跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,600 条关于
“NATCO Pharma”
全部
9,600
临床试验
4,087
药物
1,113
机构
1,220
资讯
3,180
上个月
Natco Pharma Q1FY27 Net Profit Slumps 57% as Lenalidomide Revenue Declines
24天前
NATCO Pharma Invests $14 Million in eGenesis, Deepening Its Bet on Xenotransplantation
去年
NATCO Pharma's Mekaguda API Facility Receives FDA Establishment Inspection Report Following Successful Remediation
去年
Delhi High Court Halts Natco Pharma's Generic Risdiplam Launch in Roche Patent Dispute
10个月前
Delhi High Court Allows Natco Pharma to Continue Cyantraniliprole Insecticide Sales Despite FMC Patent Dispute
上个月
Natco Pharma Q1 Profit Slumps 57% on Lenalidomide Sales Erosion; Plans ₹2,000-Crore QIP for Acquisitions
2个月前
Natco Pharma Secures USFDA Tentative Approval for Generic Olaparib Tablets, Partnering with Alembic for U.S. Distribution
去年
Natco Pharma Launches Generic Bosentan for Pediatric Pulmonary Arterial Hypertension with 180-Day US Market Exclusivity
11个月前
Delhi High Court Clears Path for Generic Risdiplam Launch, Enabling 97% Price Reduction for Rare Disease Treatment
5个月前
India's Section 3(d) and Compulsory Licensing: How Indian Patent Law Balances Innovation and Affordable Access to Life-Saving Medicines
第 1 页,共 318 页
上一页
下一页